go back

Indiana rates for HCPCS Q2055

Idecabtagene vicleucel, up to 510 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $0 · 10th–90th $0–$1,584,8930%50%90th$0Professionalmedian $562,341 · 10th–90th $562,341–$616,5950%50%90th$562,341$0.0$0.5$10.0$200.0$5.0K$100.0K$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$562,341.33 / $1,584,893.19 / $2,511,886.43
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $575,439.94
Anthem BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$0.02 / $0.02 / $660,693.45
Anthem BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $1,071,519.31
CareSource
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$562,341.33 / $831,763.77 / $1,122,018.45
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$562,341.33 / $1,047,128.55 / $1,047,128.55
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$524,807.46 / $562,341.33 / $891,250.94